ASX:GSS (Australia)  
Genetic Signatures Ltd logo

Genetic Signatures Ltd

A$ 0.83 (+3.13%) Dec 7
P/E:
36.61
P/B:
1.92
Market Cap:
A$ 118.31M ($ 79.46M)
Enterprise V:
A$ 81.45M ($ 54.70M)
Volume:
102.64K
Avg Vol (2M):
164.74K
Volume:
102.64K
Market Cap A$:
118.31M
Market Cap $:
79.46M
PE Ratio:
36.61
Avg Vol (2-Month):
164.74K
Enterprise Value A$:
81.45M
Enterprise Value $:
54.70M
PB Ratio:
1.92

Business Description

Description
Genetic Signatures Ltd is a molecular diagnostics company. The company is engaged in the development and commercialization of its proprietary platform technology, 3Base. The firm operates under one business segment namely the research and commercialisation of identifying individual genetic signatures to identify diseases and disabilities. It offers various detection kits under the brand EasyScreen in order to detect different infectious diseases including gastroenteritis, respiratory diseases, meningitis pathogens, among others.
Name Current Vs Industry Vs History
Cash-To-Debt 1085.21
Equity-to-Asset 0.92
Debt-to-EBITDA 0.01
Interest Coverage 150.79
Piotroski F-Score 8/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 16.66
Distress
Grey
Safe
Beneish M-Score -1.89
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 73.2
3-Year Book Growth Rate 55.3
Name Current Vs Industry Vs History
5-Day RSI 46.09
9-Day RSI 50.3
14-Day RSI 51.47
6-1 Month Momentum % -36.21
12-1 Month Momentum % -41.73

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 10.66
Quick Ratio 8.54
Cash Ratio 7.68
Days Inventory 306.48
Days Sales Outstanding 55.23
Days Payable 88.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -11.3